Cullen/Frost Bankers’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.6K | Sell |
169
-365
| -68% | -$55.4K | ﹤0.01% | 878 |
|
|
2025
Q1 | $80.4K | Sell |
534
-18,748
| -97% | -$2.82M | ﹤0.01% | 642 |
|
|
2024
Q4 | $3.56M | Sell |
19,282
-2,391
| -11% | -$441K | 0.05% | 214 |
|
|
2024
Q3 | $4.27M | Sell |
21,673
-3,375
| -13% | -$665K | 0.06% | 206 |
|
|
2024
Q2 | $5.17M | Sell |
25,048
-126
| -0.5% | -$26K | 0.07% | 192 |
|
|
2024
Q1 | $6.82M | Buy |
25,174
+11
| +0% | +$2.98K | 0.1% | 187 |
|
|
2023
Q4 | $5.95M | Sell |
25,163
-678
| -3% | -$160K | 0.09% | 189 |
|
|
2023
Q3 | $5.06M | Buy |
25,841
+756
| +3% | +$148K | 0.09% | 193 |
|
|
2023
Q2 | $5.27M | Buy |
25,085
+982
| +4% | +$206K | 0.09% | 192 |
|
|
2023
Q1 | $4.86M | Buy |
24,103
+20,671
| +602% | +$4.17M | 0.09% | 193 |
|
|
2022
Q4 | $748K | Sell |
3,432
-894
| -21% | -$195K | 0.01% | 330 |
|
|
2022
Q3 | $851K | Sell |
4,326
-287
| -6% | -$56.5K | 0.02% | 303 |
|
|
2022
Q2 | $987K | Buy |
4,613
+436
| +10% | +$93.3K | 0.02% | 293 |
|
|
2022
Q1 | $1.19M | Buy |
4,177
+515
| +14% | +$146K | 0.02% | 284 |
|
|
2021
Q4 | $1.38M | Sell |
3,662
-1,252
| -25% | -$472K | 0.03% | 270 |
|
|
2021
Q3 | $2.03M | Sell |
4,914
-26
| -0.5% | -$10.7K | 0.04% | 245 |
|
|
2021
Q2 | $1.83M | Buy |
4,940
+318
| +7% | +$118K | 0.04% | 251 |
|
|
2021
Q1 | $1.34M | Sell |
4,622
-53
| -1% | -$15.4K | 0.03% | 274 |
|
|
2020
Q4 | $1.17M | Sell |
4,675
-355
| -7% | -$88.7K | 0.03% | 271 |
|
|
2020
Q3 | $1.14M | Sell |
5,030
-83
| -2% | -$18.8K | 0.03% | 264 |
|
|
2020
Q2 | $891K | Buy |
5,113
+4,787
| +1,468% | +$834K | 0.02% | 287 |
|
|
2020
Q1 | $41K | Buy |
326
+103
| +46% | +$13K | ﹤0.01% | 532 |
|
|
2019
Q4 | $34K | Buy |
+223
| New | +$34K | ﹤0.01% | 670 |
|